Tokyo University of Pharmacy and Life Sciences · Department of Pharmacy / Faculty of Pharmaceutical Sciences · 教授

Research keywordspharmacovigilance・community pharmacy・drug lag・drug lag comparison・methotrexate adverse events・drug-drug interactions・spontaneous reporting systems・regional medical collaboration

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Differences in Approved Doses and Drug Lag in Drugs Approved between 2012 and 2021: A Comparison between Japan and the U.S.2025 · Biological and Pharmaceutical Bulletin
• Changes in Regional Medical Collaboration System and Functions in Community Pharmacy Before and After the Enforcement of the Amended Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices in Tokyo2024 · BPB Reports
• Status of Community Pharmacy Functions and Regional Medical Collaboration System Initiatives in Japan2024 · Biological and Pharmaceutical Bulletin
• Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use.2024 · BMC pharmacology & toxicology

• 医薬品副作用に関する医療機関報告の質を向上推進に関する研究2022 · 医薬品等規制調和・評価研究事業
• 薬剤師の職能発揮のための薬学的知見に基づく継続的な指導等の方策についての調査研究2020 · 厚生労働科学研究費
• 食の安全・リスクに関する教職員の共考と児童・生徒の学びの促進に関する研究2015 · 科学研究費助成事業

• Official profile